Infect Immun, August 1998, p. 3562-3568, Vol. 66, No. 8
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Department of Medical Microbiology and Immunology, College of Medicine, Texas A&M University Health Science Center, College Station, Texas 77843
Received 17 December 1997/Returned for modification 18 February 1998/Accepted 13 May 1998
| |
ABSTRACT |
|---|
|
|
|---|
Protein malnutrition leads to multiple detrimental alterations of
host immune responses to mycobacterial infection. In this study, we
demonstrated that splenocytes from low-protein (LP) guinea pigs
vaccinated 6 weeks previously with attenuated Mycobacterium tuberculosis H37Ra failed to control the accumulation of virulent M. tuberculosis H37Rv in cocultured autologous peritoneal
macrophages, despite the fact that they were able to control the
accumulation of virulent tubercle bacilli in cocultured syngeneic
peritoneal macrophages from normally nourished guinea pigs as
successfully as did those from high-protein (HP) counterparts.
Vaccine-induced growth control of virulent M. tuberculosis
H37Rv in these cocultures appeared to be mediated by CD4 lymphocytes
but not CD8 cells. Tuberculin (purified protein derivative
[PPD])-induced lymphoproliferation was markedly impaired in
vaccinated LP guinea pigs, and the depletion of CD4 lymphocytes
significantly decreased lymphocyte proliferation whereas CD8 cell
depletion did not. Protein malnutrition also impaired the abilities of
cells from vaccinated LP guinea pigs to produce cytokines, including
interferon, tumor necrosis factor alpha (TNF-
) and transforming
growth factor beta (TGF-
), in response to PPD, despite the
demonstration of higher serum levels of TNF-
and TGF-
after an
intravenous injection of PPD into LP guinea pigs. In contrast,
peritoneal macrophages from protein-malnourished guinea pigs produced a
higher level of TGF-
4 days after infection in vitro with M. tuberculosis H37Rv than did those from protein adequate controls.
These results suggest that dietary protein malnutrition impairs
vaccine-induced resistance to M. tuberculosis, in part, by
altering the cytokine profile to favor macrophage deactivation.
| |
INTRODUCTION |
|---|
|
|
|---|
Tuberculosis causes approximately 1.5 billion latent infections, 8 million new clinical cases, and 3 million deaths annually, making it the most prevalent infectious disease in the world (9). The emergence of multidrug-resistant tuberculosis and the pandemic of AIDS have further exacerbated the situation (1, 11). The host protective immune mechanisms against infection with Mycobacterium tuberculosis depend critically on the interactions and cooperation between monocytes-macrophages, T lymphocytes, and their cytokines (22), which are sensitive to nutritional insult (5-8, 18).
The incidence of tuberculosis is unusually high among malnourished
people, including the elderly, the homeless, alcoholics, drug abusers,
and human immunodeficiency virus-infected individuals (43).
The reactivation of latent or previously subclinical tuberculous infections may be related, in part, to deteriorating nutritional status
(42). Protein malnutrition has been identified as an important risk factor for the predisposition to intracellular infections leading to death (47). There is a strong
association between protein malnutrition and impairment of a range of
immune functions, principally those mediated by T lymphocytes, which are known to be essential for resistance to tuberculosis (18, 23,
28). Studies of experimental animals indicate that protein deprivation significantly impairs macrophage activation and granuloma development (38) and alters T-cell functions and cytokine
production (5-8, 18). Previous reports from this laboratory
have demonstrated that chronic, moderate protein deficiency severely
impairs T-cell functions and protective efficacy of M. bovis
BCG vaccination (32-34). Recently, it was reported that
protein calorie malnutrition markedly enhanced bacterial growth and
dissemination in mice infected with the attenuated BCG vaccine strain
(5) and diminished the expression of gamma interferon
(IFN-
) and tumor necrosis factor alpha (TNF-
) in the lungs of
mice infected by the intravenous route with a very high dose of the
virulent M. tuberculosis Erdman strain, resulting in rapidly
fatal tuberculosis infection and a markedly elevated bacillary load in
the lungs of protein-deficient mice (6). The precise
mechanisms by which protein malnutrition impairs host antimycobacterial
immunity remain largely unknown.
In this study, we investigated the effects of protein malnutrition on the interaction between immune lymphocytes and M. tuberculosis H37Rv-infected macrophages, the roles of CD4 and CD8 T-cell subpopulations, and the production of cytokines in M. tuberculosis H37Ra-vaccinated guinea pigs.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Experimental animals. Both pathogen-free inbred strain 2 guinea pigs (NCI-Frederick Cancer Research Facility, Frederick, Md.) and outbred Hartley strain guinea pigs (Charles River Breeding Laboratories, Inc., Wilmington, Mass.), weighing 200 to 300 g, were used in this study. The animals were individually housed in an air-filtered environment, within polycarbonate cages with stainless steel grid floors and feeders. They were given food and tap water ad libitum. Each animal was randomly assigned to an experimental diet.
Experimental diets. Purified experimental diets were obtained from a commercial supplier (Dyets, Inc., Bethlehem, Pa.) and formulated to our specifications by inversely varying the proportions of cornstarch and ovalbumin to obtain the desired protein content. The exact diet composition was published previously (30). The low-protein (LP) diet contained 10% ovalbumin, and the high-protein (HP) diet contained 30% ovalbumin. The diets were isocaloric and identical in every nutrient except protein. The third diet used was a commercial guinea pig chow (Ralston Purina, St. Louis, Mo.).
M. tuberculosis H37Ra vaccination. Two weeks after the experimental diets were started, guinea pigs were infected with viable, attenuated M. tuberculosis H37Ra (ATCC 25177; American Type Culture Collection, Rockville, Md.). Each animal received 0.1 ml of sterile physiological saline containing about 2 × 103 viable bacilli subcutaneously in the left inguinal area. The viability of the inoculum was determined by plating appropriate dilutions on Middlebrook 7H10 agar (Difco Laboratories, Detroit, Mich.).
Necropsy procedure.
Three weeks after M. tuberculosis H37Ra vaccination, all guinea pigs were treated daily
with streptomycin (40 mg/kg of body weight) and rifampin (20 mg/kg) for
3 weeks to sterilize the animals, as determined by plating lung and
spleen tissue dilutions on M7H10 agar and observing no bacillary
growth. Some guinea pigs were injected via the ear vein with purified
protein derivative (PPD; 1 mg/kg) 2 h before euthanasia.
Euthanasia was carried out by the intramuscular injection of 2 ml of
sodium pentobarbital (Fort Dodge Laboratories, Inc., Fort Dodge, Iowa).
A blood sample was obtained immediately via cardiac puncture. Sera were
separated by centrifugation and stored at
70°C until use. The
abdominal cavity of each guinea pig was opened aseptically, and the
spleen was removed for lymphocyte isolation by gentle homogenization with a glass homogenizer. The homogenates were treated with ACK lysing
buffer (0.15 M NH4Cl, 1.0 mM KHCO3, 0.1 mM
Na2EDTA [pH 7.2 to 7.4]) for 3 to 5 min at room
temperature to destroy erythrocytes, the cells were washed three times
in RPMI 1640 medium, viability was determined by trypan blue exclusion,
and the number of cells was adjusted to the desired concentration in
RPMI 1640 medium supplemented with 10% heat-inactivated fetal bovine
serum (FBS), 100 U of penicillin per ml, 100 µg of streptomycin per
ml, and 2 µM L-glutamine (working medium).
Isolation of peritoneal macrophages. Guinea pigs were injected intraperitoneally with 5 ml of 3% thioglycolate and euthanized 4 to 5 days later by intramuscular injection of 2 ml of sodium pentobarbital. The peritoneal cavity was washed with 20 ml of phosphate-buffered saline (PBS) containing 20 U of heparin per ml and 2% FBS. Peritoneal cells were collected, washed three times with and suspended in RPMI 1640 working medium, and incubated in plastic petri dishes at 37°C for 1 to 2 h. The dishes were then placed at 4°C for 20 min, and the adherent cells were scraped off, collected, washed twice in working medium, counted by the trypan blue exclusion method, and adjusted to the desired concentration in working medium without streptomycin.
Depletion of CD4 T cells, CD8 T cells, or both. For depletion of T-lymphocyte subpopulations, the following monoclonal antibodies against the specified guinea pig T-cell markers were used: CT7, anti-CD4 (35, 44); CT6, anti-CD8 (35, 44); and CT5, anti-pan-T-cell marker (4, 44). All were purchased from Serotec Inc., Partners 1, Raleigh, N.C. Different T-cell subpopulations were depleted by treatment of 5 × 106 to 1 × 107 cells with a 1:500 dilution of anti-CD4, anti-CD8, or anti-pan-T-cell marker monoclonal antibody and a 1:8 dilution of normal guinea pig serum in RPMI 1640 working medium. Lymphocyte suspensions were incubated with monoclonal antibodies for 45 min at 4°C, washed twice with 3 to 5 ml of cold PBS, and resuspended in working medium containing diluted guinea pig serum. After incubation for 30 min at 37°C, cells were washed twice and incubated with diluted serum for another 30 min at 37°C. After incubation, cells were washed three times, assessed for viability by trypan blue exclusion, and adjusted to 2 × 106 cells/ml in working medium without streptomycin. Pan-T cells, CD4 T cells, and CD8 T cells in the suspensions accounted, on average, for 34.1, 26.9, and 13.6%, respectively, before depletion and 5.4, 6.2, and 3.4%, respectively, after depletion, as determined by flow cytofluorometric analysis (26). Therefore, these depletion procedures, on average, reduced T cells by 84%, CD4 cells by 77%, and CD8 cells by 75%.
Coculture of infected macrophages and lymphocytes. Adherent peritoneal macrophages were cultured with live, dispersed virulent M. tuberculosis H37Rv organisms (ATCC 27294) at a ratio of approximately 100 macrophages per mycobacterium at 37°C for 2 to 4 h. Then differently treated lymphocytes were added, and the cells were cultured for another 7 days. The cultures were lysed with distilled water and briefly sonicated for 3 to 5 s to disperse the mycobacteria, using an Ultrasonics sonicator (Heat System-Ultrasonics, Inc., Plainview, N.Y.) with an output control setting of 3.0. The lysates were diluted in physiological saline, vigorously vortexed, and plated onto M7H10 agar plates. After incubation at 37°C for 3 weeks, the colonies were counted and expressed as CFU of mycobacteria per culture.
Preparation of lymphocyte and peritoneal macrophage culture
supernatants.
Peritoneal macrophages at 106 cells/ml
in RPMI 1640 containing 15 µg of PPD (Statens Seruminstitut,
Copenhagen, Denmark) per ml were cultured in 24-well culture plates at
1 ml per well. After incubation at 37°C in 5% CO2 for 24 or 48 h, cell-free supernatants were collected after
centrifugation of the cultures at 1,500 rpm for 10 min and stored at
70°C until use. For M. tuberculosis H37Rv-induced
production of TNF-
and transforming growth factor
1 (TGF-
1),
0.25 ml of peritoneal macrophages at 4 × 106 cells/ml
was well mixed with 0.25 ml of live, dispersed M. tuberculosis H37Rv organisms at a multiplicity of infection of 1:1
and cultured at 37°C for 4 h, and then 0.5 ml of splenocytes at
2 × 105 cells/ml was added. After incubation for
another 2 or 4 days, cell-free supernatants were collected after
centrifugation of the cultures at 1,500 rpm for 10 min and stored at
70°C until use.
70°C until
use.
TGF-
bioassay.
The Mv-1-Lu mink lung cell line (ATCC
CCL-64) was grown in Eagle's minimal essential medium containing 10%
FBS and used to measure TGF-
bioactivity as described previously
(37). Briefly, triplicate cultures were set up by seeding
2 × 104 Mv-1-Lu cells per well in 100 µl of medium
in 96-well plates and adding 100 µl of diluted samples, followed by
incubation for 24 h at 37°C in a 5% CO2 humidified
incubator. All samples were treated with 0.12 N HCl for 15 min at room
temperature and then neutralized with 0.1 M HEPES-0.144 N NaOH before
use. The cell cultures were labeled with 1 µCi of
[3H]thymidine (6.7 Ci/mmol; ICN Radiochemicals, Irvine,
Calif.) per well for the final 8 h and harvested onto fiberglass
filter disks, and the uptake of [3H]thymidine was
measured in a liquid scintillation counter (LS8000; Beckman
Instruments, Fullerton, Calif.). A standard curve was generated with
recombinant human TGF-
1 (R&D Systems, Minneapolis, Minn.) over a
concentration range of 0.008 to 4 ng/ml. This assay was sensitive to
TGF-
activity of 40 pg/ml.
TNF-
bioassay.
Macrophage culture supernatants were
assessed for TNF-
activity by measuring their cytotoxicity on L929
cells as described by Espevik et al. (12). Briefly, 0.1-ml
aliquots of L929 cell suspension (4 × 105 cells/ml)
were pipetted into 96-well culture plates and incubated overnight. The
following day, 0.1 ml of dilutions of culture supernatants or various
concentrations of recombinant human TNF-
(rhTNF-
; R&D Systems)
and actinomycin D at a final concentration of 2 µg/ml were added to
each well. After incubation for 18 h, 10 µl of MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] at a
concentration of 5 mg/ml in PBS was added, and the cells were further
cultured for 4 h. After the supernatants were decanted, 0.1 ml of
isopropanol with 0.04 N HCl was added to each well, and the plates were
incubated for 3 h. The plates were read by an enzyme-linked
immunosorbent assay (ELISA) reader (Dynatech MR 5000; Dynatech
Laboratories, Chantilly, Va.), using a test wavelength of 570 nm and a
reference wavelength of 630 nm. A standard curve was generated with
rhTNF-
. To verify that the assay was detecting TNF-
-induced
cytotoxicity, some of the supernatant samples were incubated with
rabbit anti-rhTNF-
neutralizing antibody (R&D Systems) and some with
normal rabbit immunoglobulin G at 37°C for 2 h prior to the
addition of the supernatants to the target cell cultures. This assay
was sensitive to TNF-
activity of 25 pg/ml.
IFN bioassay.
Total IFN bioactivity in the culture
supernatants was measured by inhibition of the cytopathic effect of
vesicular stomatitis virus (VSV) on mouse L929 cells (19).
Briefly, serial twofold dilutions of 50 µl of IFN-containing
supernatants were made in Iscove's modified Dulbecco medium
(GIBCO BRL, Grand Island, N.Y.) without serum in a 96-well
plate, and 0.1 ml of L929 cells (5 × 104 cells) was
added per well. Following overnight incubation, cells were challenged
with 50 µl of VSV at a multiplicity of infection of 1. After
incubation for 24 h, the supernatant from each well was removed,
and the cells were washed and fixed with 0.1 ml of 5% formalin at room
temperature for 10 min. Then the cells were washed and stained with 0.1 ml of crystal violet solution for 10 min. Finally, the plate was rinsed
and dried. After addition of 0.1 ml of 100% methanol to each well, the
plates were read at 595 nm on a microtiter ELISA plate reader. A
standard curve was generated with recombinant human IFN-
(R&D
Systems). This assay was sensitive to IFN-
activity of 20 U/ml but
detects all three species of IFN.
Lymphocyte blastogenesis. Splenocytes were distributed into 96-well flat-bottom tissue culture plates (Corning Glass Works, Corning, N.Y.) at 2 × 105 cells per well in RPMI 1640 working medium. Triplicate cultures were stimulated with PPD at a final concentration of 15 µg/ml. For some experiments, 10 µg of anti-human interleukin-2 (IL-2) antibody (Genzyme Corporation, Cambridge, Mass.) per ml was added to the cultures. The cultures were incubated for 3 days at 37°C in a 5% CO2 atmosphere, labeled with 1.0 µCi of tritiated thymidine per well for another 18 h, and harvested onto glass wool fiber filters, using a cell harvester. [3H]thymidine incorporation into cellular DNA was measured in a liquid scintillation counter. The results were expressed as mean net counts per minute (counts per minute in stimulated wells minus counts per minute in control wells).
Statistical analysis. The analysis of variance was used to test for the effect of dietary treatment on the dependent variables measured. When appropriate, Student's t test was used to analyze the significance of differences between group means. A 95% confidence level was set for all tests.
| |
RESULTS |
|---|
|
|
|---|
Influence of dietary protein malnutrition on the growth containment of M. tuberculosis H37Rv induced in peritoneal macrophages by M. tuberculosis H37Ra-primed T lymphocytes. The initial experiments showed that cocultures of peritoneal macrophages with syngeneic splenocytes from inbred strain 2 guinea pigs vaccinated 6 weeks previously with viable, attenuated M. tuberculosis H37Ra inhibited the growth of virulent tubercle bacilli in a dose-dependent fashion (Fig. 1). In cocultures with syngeneic peritoneal macrophages derived from normally nourished donor guinea pigs, splenocytes from LP guinea pigs vaccinated 6 weeks previously with M. tuberculosis H37Ra were able to control the accumulation of virulent tubercle bacilli in cultured macrophages as successfully as those from HP guinea pigs (Fig. 2). Only the CD4 T-cell population appeared to be necessary in both diet groups to mediate antituberculosis resistance, as evidenced by the abrogation of this vaccine-induced bacillary control by the depletion of CD4 T lymphocytes, or CD4 plus CD8 T cells, but not by the depletion of CD8 cells alone (Fig. 2).
|
|
PPD-driven lymphocyte blastogenesis. Figure 3 illustrates the impact of protein malnutrition on the proliferative response of splenocytes 6 weeks following M. tuberculosis H37Ra vaccination. Lymphocytes derived from LP guinea pigs had a markedly depressed proliferative response to PPD compared with that from HP guinea pigs (P < 0.01). Lymphocyte subpopulation depletions revealed that CD4 T-cell depletion significantly reduced the PPD-induced lymphoproliferation in HP guinea pigs (P < 0.05), while CD8 T-cell depletion did not. In contrast, neither CD4 nor CD8 T-cell depletion significantly altered the suppressed PPD-induced responses of splenocytes from LP guinea pigs. These results suggest that protein malnutrition alters the development and/or proliferative function of antigen-specific lymphocytes.
|
Impact of protein malnutrition on the production of cytokines.
The effect of dietary protein malnutrition on TNF-
production was
evaluated by measuring TNF-
bioactivity in the sera of M. tuberculosis H37Ra-vaccinated guinea pigs with or without
intravenous injection of PPD and in the culture supernatants of
peritoneal macrophages stimulated with PPD or infected with M. tuberculosis H37Rv (Table 1). Six
weeks following vaccination, sera were separated by centrifugation of
blood samples and measured for TNF-
bioactivity. Protein
malnutrition resulted in a significantly higher serum level of
bioactive TNF-
in guinea pigs vaccinated with M. tuberculosis H37Ra. An intravenous injection of PPD boosted
remarkably the serum level of bioactive TNF-
in both LP and HP
guinea pigs, with the level of TNF-
in sera from LP guinea pigs
rising significantly higher than that from HP guinea pigs (P < 0.001). In contrast, peritoneal macrophages derived from HP guinea pigs
produced a much higher amount of TNF-
than did those from LP guinea
pigs when stimulated in vitro with PPD (P < 0.01) or infected
with M. tuberculosis H37Rv for 2 and 4 days (P < 0.001). These results indicate that protein malnutrition impairs the
capacity of macrophages to produce TNF-
in response to mycobacteria
and their antigens, at least in vitro, and that elevated serum TNF
bioactivity in LP animals may not be due to increased production by
macrophages.
|
in their serum
than HP guinea pigs after an intravenous injection of PPD (P < 0.05), while peritoneal macrophages from LP guinea pigs produced
significantly less TGF-
in response to PPD in vitro than did those
from HP guinea pigs (P < 0.01). In contrast, as seen in Fig.
5, peritoneal macrophages from immune LP
guinea pigs produced a significantly higher level of TGF-
when
infected with M. tuberculosis H37Rv for 4 days than did
those from HP guinea pigs (P < 0.01).
|
|
| |
DISCUSSION |
|---|
|
|
|---|
The detrimental effects of nutritional deficiencies on tuberculosis could result from alterations in the individual protective functions of, or the interaction between, T lymphocytes and macrophages, which are the major cell types mediating antimycobacterial immunity (15, 22, 39). In the present study, we demonstrated that splenocytes derived from inbred strain 2 protein-malnourished guinea pigs vaccinated previously with M. tuberculosis H37Ra were able to cooperate with syngeneic macrophages from normally nourished donors to control the accumulation of virulent tubercle bacilli inside infected macrophages (Figure 2) but not with autologous macrophages from the same protein-deficient environment. The fact that lymphocytes from LP guinea pigs could activate macrophages from normally nourished guinea pigs suggests that protein deficiency did not alter this activity, at least in vitro. On the other hand, the inability of LP lymphocytes to activate LP macrophages provides evidence that protein malnutrition impairs the productive interaction between macrophages and T lymphocytes and/or the acquisition of mycobactericidal-mycobacteriostatic activity by LP macrophages in the presence of adequate activation signals.
Adoptive transfer experiments conducted previously in this laboratory demonstrated that immune lymphocytes derived from protein-deficient guinea pigs have a relatively low ability to protect normally nourished recipients from respiratory challenge with virulent M. tuberculosis H37Rv, indicating that protein deficiency prevented guinea pigs from generating a population of antigen-specific immune lymphocytes and/or impaired the proliferative capacity of these cells (27). In this study, we demonstrated that immune lymphocytes derived from protein-deficient guinea pigs responded poorly to PPD (Fig. 3) and were unable to control the accumulation of virulent tubercle bacilli in the cocultures with autologous macrophages. These findings could be interpreted to result from a defective generation of antigen-specific immune lymphocytes caused by protein deficiency because little evidence for macrophage defects in protein-deficient guinea pigs was found in previous studies (24, 31, 33). This interpretation is compatible with the results of adoptive transfer experiments described above (27). Further experiments will be carried out to verify if there is a defective generation of antigen-specific immune lymphocytes in LP guinea pigs or if the defect is in cell-to-cell communication. The observation that immune lymphocytes from protein-deficient guinea pigs were able to activate macrophages from normally nourished guinea pigs to control the growth of virulent mycobacteria in vitro could be explained by the relatively high number of immune lymphocytes concentrated in the cocultures and the closeness of contact between lymphocytes and macrophages, which may facilitate the generation of adequate activation signals for macrophages and thus compensate for the functional alteration of these cells.
Both CD4 and CD8 T cells have been shown to be required in the control of mycobacterial infection in mice (14, 25, 36). However, the precise role of each of these cell types has not been fully elucidated, and no data on the role of T-cell subsets in the guinea pig have been published. In our in vitro macrophage coculture system, CD4 T cells were demonstrated to be the major effector cells in containing the growth of virulent M. tuberculosis H37Rv, while the depletion of CD8 T cells did not alter the outcome (Figure 2). This result suggests that CD8 T cells contribute little, if any, to the growth control of virulent tubercle bacilli either by mediating target cell lysis or by cytokine production in this coculture system. Immunization with M. tuberculosis H37Ra, which is attenuated and thought to reside exclusively in the phagosome (39), may not effectively activate major histocompatibility complex class I-restricted CD8 T cells. Therefore, one reasonable explanation for our result is that very few, if any, antigen-reactive CD8 T cells are present in the cocultures.
Cytokines play a central role in mediating antimycobacterial immunity.
IL-2 is required to initiate and amplify immune responses. IFN-
and
TNF-
are important macrophage-activating cytokines and crucial in
the immune response to tuberculosis (10, 13). Depressed
production of IL-2 (21, 45) and IFN-
(21, 40) in patients with chronic pulmonary tuberculosis has been reported. Similarly, IL-2 production was depressed in chronically
protein-deficient guinea pigs vaccinated with M. bovis BCG
(29), and TNF-
and IFN-
expression was reportedly
decreased in protein calorie-malnourished mice infected intravenously
with a lethal dose of the virulent M. tuberculosis Erdman
strain (6). In this study, the capacity of splenocytes and
macrophages to produce total bioactive IFN and TNF-
in vitro (Table
1) was found to be suppressed. The decreased production of these
cytokines at the site of immune inflammatory responses may be
responsible for the impairment of overall host antimycobacterial
resistance in protein-deficient guinea pigs. IFN-
is a key cytokine
in the development of Th1-type immune responses which are required for
the elimination of intracellular pathogens, including mycobacteria
(41, 48). IFN-
induces major histocompatibility class II
expression and thus increases antigen processing and presentation by
monocytes-macrophages to CD4 T lymphocytes (2). It also
induces differentiation and activation of monocyte-macrophages and
enhances their intracellular microbicidal activity (6).
Therefore, IFN-
is crucial in the immune response to mycobacterial
infection (9, 13). The present study revealed that total
bioactive IFN produced by immune splenocytes in protein-malnourished
guinea pigs was depressed. This decrease is most likely due to the
depressed production of IFN-
because protein malnutrition has been
observed to cause marked depletion of T lymphocytes (23, 28)
and profound depression of NK cell activity (20) in the
spleen, resulting in IFN-
-secreting cell loss and functional defect.
Moreover, IL-2 production, upon which IFN-
production is dependent,
was depressed in earlier studies with protein-malnourished guinea pigs
(29). All of these alterations induced by protein
malnutrition may contribute to the depressed production of IFN-
.
Dietary protein malnutrition impaired TNF-
production by peritoneal
macrophages. In contrast, intravenous injection of PPD triggered a
higher level of TNF-
in the serum of LP guinea pigs (Table 1). One
possible explanation is that vaccination with M. tuberculosis H37Ra may trigger inflammatory and immune responses in guinea pigs on the LP diet different from those in guinea pigs on
the HP diet. It is also possible that protein deficiency results in
leakage of lipopolysaccharide from the gut, which primes macrophages to
respond more dramatically to PPD in terms of TNF-
production.
TGF-
production could be influenced by many factors, including the
type and state of activation of cells, external stimuli, and the
presence of other cytokines. A study by Chandrasekar et al. revealed
that restricting dietary calories significantly increased mRNA and
protein expression of TGF-
and decreased those of proinflammatory cytokines, including IL-6 and TNF-
, in autoimmune prone mice (8). Bermudez reported that TGF-
production by human
monocyte-derived macrophages infected in vitro with M. avium
isolates was bacterial strain dependent and was more pronounced in
macrophages infected with a virulent strain (3). In this
study, we found that the serum of protein-deprived guinea pigs had
higher levels of bioactive TGF-
, while peritoneal macrophages from
protein-deficient guinea pigs had a depressed ability to produce
TGF-
in response to PPD (Fig. 4). Decreased TGF-
production in
response to PPD may reflect impairment of the ability of peritoneal
macrophages from protein-deficient guinea pigs to generate stimulating
components for TGF-
production. In fact, peritoneal macrophages from
protein-deficient guinea pigs produced significantly more
bioactive TGF-
when infected with virulent M. tuberculosis H37Rv in vitro for 4 days compared to
peritoneal macrophages from control diet guinea pigs (Fig. 5). There
was no difference between the diet treatment groups at 2 days (Fig. 5).
Given the slow replication rate of the bacilli, it is not surprising
that time in culture might be an important variable. One possible
explanation for the discrepancy between the effect of diet on the
production of TGF-
by macrophages exposed to PPD, in contrast to
viable M. tuberculosis, is that peritoneal macrophages from
protein-deficient guinea pigs cannot control the intracellular
multiplication of virulent mycobacteria as successfully as those from
control diet-fed animals, and thus mycobacteria grow faster and secrete
more proteins inside LP peritoneal macrophages. Some proteins
secreted by viable mycobacteria which are not necessarily found in
PPD could trigger TGF-
release from these infected macrophages.
Taken together, the results of this study demonstrate that protein
malnutrition has multiple detrimental effects on host antimycobacterial resistance. First, dietary protein malnutrition impairs macrophage functions, including TNF-
production and cooperation with T
lymphocytes to control mycobacterial growth in vitro; second, it causes
remarkable depression of T-lymphocyte functions, as indicated by
reductions in PPD-driven proliferation and Th1 cytokine (IFN-
)
production; third, protein malnutrition potentiates live M. tuberculosis H37Rv-infected monocytes-macrophages to produce
higher levels of TGF-
, which is a likely mediator of
immunosuppression and immunopathogenesis in tuberculosis (16, 17,
46).
| |
ACKNOWLEDGMENT |
|---|
This work was supported in part by PHS grant AI-15495 from NIH.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Medical Microbiology and Immunology, College of Medicine, Texas A&M University Health Science Center, College Station, TX 77843. Phone: (409) 845-1367. Fax: (409) 845-3479. E-mail: dmcmurray{at}tamu.edu.
Editor: S. H. E. Kaufmann
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Barnes, P. F., A. B. Bloom, P. T. Davidson, and P. E. Snider, Jr. 1991. Tuberculosis in patients with human immunodeficiency virus infection. N. Engl. J. Med. 324:1644-1650[Medline]. |
| 2. |
Basham, T. Y., and T. C. Merigan.
1983.
Recombinant interferon- increases HLA-DR synthesis and expression.
J. Immunol.
130:1492-1494[Abstract].
|
| 3. |
Bermudez, L. E.
1993.
Production of transforming growth factor- by Mycobacterium avium-infected human macrophages is associated with unresponsiveness to IFN- .
J. Immunol.
150:1838-1845[Abstract].
|
| 4. | Burger, R., and H. Schafer. 1988. Differentiation antigens on lymphoid cells of the guinea pig, p. 249-287. In M. Miyasaka, and Z. Trnka (ed.), Differentiation antigens in lymphohemopoietic tissue. Marcel Dekker, New York, N.Y. |
| 5. | Chan, J., K. E. Tanaka, C. Mannion, D. Carroll, M. S. Tsang, Y. Xing, C. Lowenstein, and B. R. Bloom. 1997. Effects of protein calorie malnutrition on mice infected with BCG. J. Nutr. Immunol. 5:11-19. |
| 6. | Chan, J., Y. Tian, K. E. Tanaka, M. S. Tsang, K. Yu, P. Salgame, D. Carroll, Y. Kress, R. Teitelbaum, and B. R. Bloom. 1996. Effects of protein calorie malnutrition on tuberculosis in mice. Proc. Natl. Acad. Sci. USA 93:14875-14861. |
| 7. | Chandra, R. K. 1992. Protein-energy malnutrition and immunological responses. J. Nutr. 122:597-600. |
| 8. |
Chandrasekar, B.,
H. S. McGuff,
T. B. Aufdermorte,
D. A. Troyer,
N. Talal, and G. Fernandes.
1995.
Effects of calorie restriction on transforming growth factor 1 and proinflammatory cytokines in murine Sjogren's syndrome.
Clin. Immunol. Immunopathol.
76:291-296[Medline].
|
| 9. | Collins, F. M. 1993. Tuberculosis: the return of an old enemy. Crit. Rev. Microbiol. 19:1-16[Medline]. |
| 10. |
Cooper, A. M.,
D. K. Dalton,
T. A. Steward,
J. P. Griffin,
D. G. Russell, and I. A. Orme.
1993.
Disseminated tuberculosis in interferon gene-disrupted mice.
J. Exp. Med.
178:2243-2247 |
| 11. | Dooley, S. W., W. R. Jarvis, W. J. Martone, and P. E. Snider, Jr. 1992. Multidrug resistant tuberculosis. Ann. Intern. Med. 117:257-258. |
| 12. | Espevik, T., and J. Nissen-Meyer. 1986. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J. Immunol. Methods 95:99-105[Medline]. |
| 13. |
Flynn, J. L.,
K. J. Triebold,
D. K. Palton,
T. A. Steward, and B. R. Bloom.
1993.
An essential role of interferon in resistance to Mycobacterium tuberculosis infection.
J. Exp. Med.
178:2249-2254 |
| 14. |
Flynn, J. L.,
M. M. Goldstein,
K. J. Jriebold,
B. Koller, and B. R. Bloom.
1992.
Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection.
Proc. Natl. Acad. Sci. USA
89:12013-12017 |
| 15. | Hahn, H., and S. H. Kaufmann. 1981. The role of cell-mediated immunity in bacterial infections. Res. Infect. Dis. 3:1221-1250. |
| 16. |
Hirsch, C. S.,
S. H., R. Hussain,
Z. Toossi,
G. Dawood,
F. Shahid, and J. J. Ellner.
1996.
Cross-modulation by transforming growth factor in human tuberculosis: suppression of antigen-driven blastogenesis and interferon production.
Proc. Natl. Acad. Sci. USA
93:3193-3198 |
| 17. | Hirsch, C. S., T. Yoneda, L. E. Averill, J. J. Ellner, and Z. Toossi. 1994. Enhancement of intracellular growth of Mycobacterium tuberculosis in human monocytes by transforming growth factor-b1. J. Infect. Dis. 170:1229-1237[Medline]. |
| 18. | Hoffman-Goetz, L. 1988. Lympokines and monokines in protein-energy malnutrition, p. 9-23. In R. K. Chandra (ed.), Nutrition and immunology. Alan R. Liss, Inc., New York, N.Y. |
| 19. |
Huygen, K.,
K. Paleliet,
F. Jurio,
J. Hilgers,
R. T. Berg,
J. P. V. Vooren, and J. D. Bruyn.
1988.
H-2-linked control of in vitro gamma interferon production in response to a 32-kilodalton antigen (P32) of Mycobacterium bovis bacillus Calmette-Guérin.
Infect. Immun.
56:3196-3200 |
| 20. | Ingram, K. G., B. A. Croy, and B. D. Woodward. 1995. Splenic natural killer cell activity in wasted, protein-energy malnourished weanling mice. Nutr. Res. 15:231-243. |
| 21. |
Johnson, B. J., and D. N. McMurray.
1994.
Cytokine gene expression by cultures of human lymphocytes with autologous Mycobacterium tuberculosis-infected monocytes.
Infect. Immun.
62:1444-1450 |
| 22. | Kaufmann, S. H. E., and I. E. A. Flesch. 1988. The role of T cell-macrophage interactions in tuberculosis. Springer Semin. Immunopathol. 10:337-358[Medline]. |
| 23. | Keusch, G. T., C. S. Wilson, and S. D. Waksal. 1983. Nutrition, host defenses, and lymphoid system, p. 275-359. In J. I. Gallin, and A. S. Fauci (ed.), Advances in host defense mechanisms. Raven Press, New York, N.Y. |
| 24. | Keusch, G. T., D. S. Douglas, G. Hammer, and K. Braden. 1978. Antibacterial functions of macrophages in experimental protein calorie malnutrition. II. Cellular and humoral factors for chemotaxis, phagocytosis and intracellular bactericidal activity. J. Infect. Dis. 138:134-142[Medline]. |
| 25. | Ladel, C. H., S. Daugelat, and S. H. E. Kaufmann. 1995. Immune response to Mycobacterium bovis bacille Calmette Guerin infection in major histocompatibility complex class I- and class II-deficient knock-out mice: contribution of CD4 and CD8 T cells to acquired resistance. Eur. J. Immunol. 25:377-384[Medline]. |
| 26. |
Mainali, E. S., and D. N. McMurray.
1998.
Protein deficiency induces alterations in the distribution of T-cell subsets in experimental pulmonary tuberculosis.
Infect. Immun.
66:927-931 |
| 27. | Mainali, E. S., and D. N. McMurray. 1998. Adoptive transfer of resistance to pulmonary tuberculosis in guinea pigs is altered by protein deficiency. Nutr. Res. 18:309-317. |
| 28. | McMurray, D. N. 1984. Cell-mediated immunity in nutritional deficiency. Prog. Food Nutr. Sci. 8:193-228[Medline]. |
| 29. |
McMurray, D. N.,
C. L. Mintzer,
R. A. Bartow, and R. L. Parr.
1989.
Dietary protein deficiency and Mycobacterium bovis BCG affect interleukin-2 activity in experimental pulmonary tuberculosis.
Infect. Immun.
57:2606-2611 |
| 30. |
McMurray, D. N., and E. A. Yetley.
1983.
Response to Mycobacterium bovis BCG vaccination in protein- and zinc-deficient guinea pigs.
Infect. Immun.
39:755-761 |
| 31. | McMurray, D. N., E. A. Yetley, and T. Burch. 1981. Effect of malnutrition and BCG vaccination on macrophage activation in guinea pigs. Nutr. Res. 1:373-384. |
| 32. |
McMurray, D. N.,
M. A. Carlomagno,
C. L. Mintzer, and C. L. Tetzlaff.
1985.
Mycobacterium bovis BCG vaccine fails to protect protein-deficient guinea pigs against respiratory challenge with virulent Mycobacterium tuberculosis H37Rv.
Infect. Immun.
50:555-559 |
| 33. | McMurray, D. N., M. S. Kimball, C. L. Tetzlaff, and C. L. Mintzer. 1986. Effects of protein deprivation and BCG vaccination on alveolar macrophage function in pulmonary tuberculosis. Am. Rev. Respir. Dis. 133:1081-1085[Medline]. |
| 34. | McMurray, D. N., R. A. Bartow, C. L. Mintzer, and E. Hernandez-Frontera. 1990. Micronutrient status and immune function in tuberculosis. Ann. N. Y. Acad. Sci. 587:59-69[Abstract]. |
| 35. | McPhee, C. A., J. I. Milton, and A. W. Thomson. 1988. Flow cytometric analysis of lymphocyte populations in guinea pig blood and spleen. Ia antigen-expression and the effects of immunosuppressive agents. Int. Arch. Allergy Appl. Immunol. 87:275-282[Medline]. |
| 36. |
Muller, I.,
S. P. Cobbold,
H. Waldmann, and S. H. E. Kaufmann.
1987.
Impaired resistance to Mycobacterium tuberculosis infection after selective in vivo depletion of L3T4+ and Lyt-2+ cells.
Infect. Immun.
55:2037-2041 |
| 37. | Ranchallis, J. E., L. Gentry, Y. Ogawa, S. M. Seyedin, J. McPherson, A. Purchio, and D. R. Twardzik. 1987. Bone-derived and recombinant transforming growth factor beta are potent inhibitors of tumor cell growth. Biochem. Biophys. Res. Commun. 148:783-789[Medline]. |
| 38. | Reynolds, J. V., H. P. Redmond, N. Ueno, C. Steigman, M. M. Ziegler, J. M. Daly, and R. B. Johnston, Jr. 1992. Impairment of macrophage activation and granuloma formation by protein deprivation in mice. Cell. Immunol. 139:493-504[Medline]. |
| 39. | Rook, G. A. W., and R. Hernandez-Pando. 1996. The pathogenesis of tuberculosis. Annu. Rev. Microbiol. 50:258-284. |
| 40. |
Sanchez, F. O.,
J. I. Rodriguez,
G. Agudelo, and L. F. Garcia.
1994.
Immune responsiveness and lymphokine production in patients with tuberculosis and healthy controls.
Infect. Immun.
62:5673-5678 |
| 41. | Scott, P., and S. H. E. Kaufmann. 1991. The role of T-cell subsets and cytokines in the regulation of infection. Immunol. Today 12:346-352[Medline]. |
| 42. | Stead, W. W., and A. K. Dutt. 1988. Interactions with the immune system, p. 371-377. In M. Bendinelli, and H. Friedman (ed.), Mycobacterium tuberculosis. Plenum Publishing Corp., New York, N.Y. |
| 43. | Sudre, P., G. Dam, and A. Kochi. 1992. Tuberculosis: a global overview of the situation today. Bull. W. H. O. 70:149-159[Medline]. |
| 44. | Tan, B. T. G., F. Ekelaar, J. Cuirink, G. Rimmelzwaan, A. J. R. De Jonge, and R. J. Scheper. 1985. Production of monoclonal antibodies defining guinea pig T cell surface markers and a strain 13 Ia-like antigen: the value of immunohistological screening. Hybridoma 4:115-122[Medline]. |
| 45. |
Toossi, Z.,
M. E. Kleinhenz, and J. J. Ellner.
1986.
Defective interleukin 2 production and responsiveness in human pulmonary tuberculosis.
J. Exp. Med.
163:1162-1172 |
| 46. | Tsunawaki, S., M. Sporn, A. Ding, and C. Nathan. 1988. Deactivation of macrophages by transforming growth factor beta. Nature 334:260-262[Medline]. |
| 47. | Tupasi, T. E., M. A. Velmonte, M. E. G. Sanvictores, L. Abramham, L. E. D. Leon, S. A. Tan, C. A. Miguel, and M. C. Saniel. 1988. Determinants of morbidity and mortality due to acute respiratory infections: implications and intervention. J. Infect. Dis. 157:615-623[Medline]. |
| 48. |
Young, H. A., and K. J. Hardy.
1995.
Role of interferon- in immune cell regulation.
J. Leukocyte Biol.
58:373-381[Abstract].
|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|